Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
11 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Pemazyre“
Suchtreffer
Begriffe & Kennungen
Pemazyre · 4.8 · Hyperphosphataemia Hyperphosphataemia was reported in 60.5 % of all patients treated with pemigatinib. Hyperph
Eintrag öffnenPemazyre · 4.8 · Onychalgia, Onychoclasis, Onycholysis, Onychomadesis, Onychomycosis and Paronychia
Eintrag öffnenPemazyre · 4.8 · Recommendations for management of hyperphosphataemia are provided in sections 4.2 and 4.4.
Eintrag öffnenPemazyre · 4.8 · Recommendations for management of serous retinal detachment are provided in sections 4.2 and 4.4.
Eintrag öffnenPemazyre · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenPemazyre · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenPemazyre · 4.8 · Serous retinal detachment Serous retinal detachment occurred in 4.8 % of all patients treated with pemigatinib
Eintrag öffnenPemazyre · 4.8 · Subretinal fluid, Chorioretinal folds, Chorioretinal scar, and Maculopathy. See below “Serous retinal detachme
Eintrag öffnenPemazyre · 4.8 · Summary of the safety profile The most common adverse reactions were hyperphosphataemia (60.5 %), alopecia (49
Eintrag öffnenPemazyre · 4.8 · Table 4: Adverse reactions reported in clinical studies System organ class Frequency Adverse reactions Metabol
Eintrag öffnenPemazyre · 4.8 · The most common serious adverse reactions were hyponatremia (2.0 %) and blood creatinine increase (1.4 %). No
Eintrag öffnen